A public healthcare solution company listed in Shanghai Stock Exchange (603716.SH) with focus on IVD integrated supplying, in-hospital intelligent SPD operations and management, IVD innovation and distribution and providing laboratory testing & diagnosis services. Headquartered in Wuhan city & Shanghai with more than 45 subsidiaries and 1,200+ associates around China.
There is no investment information
No recent news or press coverage available for Thalys Medical Technology Group Corporation.